← Open Payments lookup

KIMBERLY ESSER: Open Payments

NPI 1699187393 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$542 in 30 payments from 12 companies in 2025. Trend: 2023 $1,333 · 2024 $778 · 2025 $542

Food & beverage: $542
CompanyPaymentsAmount
ABBVIE INC.6$109
Lilly USA, LLC6$105
UCB, Inc.3$67
Merck Sharp & Dohme LLC2$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$38
GlaxoSmithKline, LLC.2$36
Amgen Inc.2$34
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Antares Pharma, Inc.1$21
Phathom Pharmaceuticals, Inc.2$20

Products named: MOUNJARO, UBRELVY, Fintepla, GARDASIL 9, XIFAXAN, EVENITY, CAPLYTA, QULIPTA.

Industry payments across MS — which companies pay providers there.